PANACEA BIOTEC
Back to Balance Sheet
|
PANACEA BIOTEC Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹104 Cr | ₹265 Cr | ₹271 Cr | ₹85 Cr | ₹960 Cr |
What is the latest Total Non-Current Liabilities ratio of PANACEA BIOTEC ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹104 Cr |
| Mar2024 | ₹265 Cr |
| Mar2023 | ₹271 Cr |
| Mar2022 | ₹85 Cr |
| Mar2021 | ₹960 Cr |
How is Total Non-Current Liabilities of PANACEA BIOTEC Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹104 Cr | -60.91 | |
| Mar2024 | ₹265 Cr | -2.07 | |
| Mar2023 | ₹271 Cr | 218.11 | |
| Mar2022 | ₹85 Cr | -91.14 | |
| Mar2021 | ₹960 Cr | - | |
Compare Total Non-Current Liabilities of peers of PANACEA BIOTEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PANACEA BIOTEC | ₹2,372.3 Cr | 1.5% | 11.6% | -25.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
PANACEA BIOTEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PANACEA BIOTEC | 1.5% |
11.6% |
-25.3% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses